IL142460A0 - A vitreous form of 8-[3-[n-[(e)-3-(6-acetamidopyridin-3-yl) acryloyl-glycyl] -n-methylamino] -2,6-dichlorobenzyloxy]-2-methylquinoline - Google Patents

A vitreous form of 8-[3-[n-[(e)-3-(6-acetamidopyridin-3-yl) acryloyl-glycyl] -n-methylamino] -2,6-dichlorobenzyloxy]-2-methylquinoline

Info

Publication number
IL142460A0
IL142460A0 IL14246099A IL14246099A IL142460A0 IL 142460 A0 IL142460 A0 IL 142460A0 IL 14246099 A IL14246099 A IL 14246099A IL 14246099 A IL14246099 A IL 14246099A IL 142460 A0 IL142460 A0 IL 142460A0
Authority
IL
Israel
Prior art keywords
acetamidopyridin
dichlorobenzyloxy
methylquinoline
glycyl
acryloyl
Prior art date
Application number
IL14246099A
Other languages
English (en)
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of IL142460A0 publication Critical patent/IL142460A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)
IL14246099A 1998-10-21 1999-10-07 A vitreous form of 8-[3-[n-[(e)-3-(6-acetamidopyridin-3-yl) acryloyl-glycyl] -n-methylamino] -2,6-dichlorobenzyloxy]-2-methylquinoline IL142460A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP29925298 1998-10-21
PCT/JP1999/005519 WO2000023439A1 (en) 1998-10-21 1999-10-07 Vitreous form of known bradykinin antagonist

Publications (1)

Publication Number Publication Date
IL142460A0 true IL142460A0 (en) 2002-03-10

Family

ID=17870134

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14246099A IL142460A0 (en) 1998-10-21 1999-10-07 A vitreous form of 8-[3-[n-[(e)-3-(6-acetamidopyridin-3-yl) acryloyl-glycyl] -n-methylamino] -2,6-dichlorobenzyloxy]-2-methylquinoline

Country Status (18)

Country Link
US (2) US6509468B1 (xx)
EP (1) EP1123288A1 (xx)
JP (1) JP3353784B2 (xx)
KR (1) KR100419404B1 (xx)
CN (1) CN1144801C (xx)
AR (1) AR024220A1 (xx)
AU (1) AU756479B2 (xx)
BR (1) BR9914785A (xx)
CA (1) CA2347001A1 (xx)
CZ (1) CZ20011417A3 (xx)
HK (1) HK1040245B (xx)
HU (1) HUP0104110A3 (xx)
IL (1) IL142460A0 (xx)
RU (1) RU2202550C2 (xx)
TR (1) TR200101101T2 (xx)
TW (1) TWI230158B (xx)
WO (1) WO2000023439A1 (xx)
ZA (1) ZA200102607B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001092254A1 (fr) * 2000-05-30 2001-12-06 Fujisawa Pharmaceutical Co., Ltd. Procede permettant de remplacer des solvants contenus dans des cristaux de type clathrates
EP1495017A2 (en) * 2002-04-10 2005-01-12 Ortho-McNeil Pharmaceutical, Inc. Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
TWI407960B (zh) 2007-03-23 2013-09-11 Jerini Ag 小分子緩激肽b2受體調節劑
AR113839A1 (es) 2017-11-24 2020-06-17 Pharvaris B V Antagonistas del receptor b2 de bradiquinina
UY38706A (es) 2019-05-23 2020-12-31 Pharvaris Gmbh Antagonistas cíclicos del receptor b2 de bradiquinina
AR118983A1 (es) 2019-05-23 2021-11-17 Pharvaris Gmbh Antagonistas cíclicos del receptor b2 de bradiquinina
WO2023180575A1 (en) 2022-03-25 2023-09-28 Pharvaris Gmbh Solid composition comprising solubilised bradykinin b2-receptor antagonists
TW202345810A (zh) 2022-03-25 2023-12-01 瑞士商帕法瑞斯有限責任公司 包含緩激肽b2受體拮抗劑之固態延長釋放組成物
WO2023180577A1 (en) 2022-03-25 2023-09-28 Pharvaris Gmbh Therapeutic uses of bradykinin b2-receptor antagonists

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US558455A (en) * 1896-04-14 Thomas lewty
AU680870B2 (en) * 1993-04-28 1997-08-14 Astellas Pharma Inc. New heterocyclic compounds
JP3049648B2 (ja) 1993-12-13 2000-06-05 日立金属株式会社 加圧成形方法および加圧成形機
US5958455A (en) * 1996-02-09 1999-09-28 Quadrant Holdings Cambridge Ltd Oral solid dosage forms, methods of making same and compositions thereof
JPH10316677A (ja) * 1997-05-19 1998-12-02 Fujisawa Pharmaceut Co Ltd 結 晶

Also Published As

Publication number Publication date
BR9914785A (pt) 2001-07-03
US7094899B2 (en) 2006-08-22
HK1040245B (zh) 2004-10-08
KR20010075445A (ko) 2001-08-09
EP1123288A1 (en) 2001-08-16
JP2002527514A (ja) 2002-08-27
TWI230158B (en) 2005-04-01
CZ20011417A3 (cs) 2001-09-12
CA2347001A1 (en) 2000-04-27
US6509468B1 (en) 2003-01-21
AR024220A1 (es) 2002-09-25
JP3353784B2 (ja) 2002-12-03
AU6004399A (en) 2000-05-08
CN1324354A (zh) 2001-11-28
TR200101101T2 (tr) 2001-09-21
KR100419404B1 (ko) 2004-02-21
AU756479B2 (en) 2003-01-16
RU2202550C2 (ru) 2003-04-20
HUP0104110A3 (en) 2003-01-28
ZA200102607B (en) 2002-07-01
US20030120076A1 (en) 2003-06-26
HK1040245A1 (en) 2002-05-31
CN1144801C (zh) 2004-04-07
HUP0104110A2 (hu) 2002-03-28
WO2000023439A1 (en) 2000-04-27

Similar Documents

Publication Publication Date Title
GB9828812D0 (en) Gas turbine nose cone assembly
EG24178A (en) Calcilytic compounds
GB9801902D0 (en) A gene promoter
IL142460A0 (en) A vitreous form of 8-[3-[n-[(e)-3-(6-acetamidopyridin-3-yl) acryloyl-glycyl] -n-methylamino] -2,6-dichlorobenzyloxy]-2-methylquinoline
GB9904659D0 (en) Dephlegmator
HUP0104193A3 (en) An improved process for the preparation of new antidiabetic agents
ZA997446B (en) Lowering blood levels of lipoprotein(a).
AU7469598A (en) Thermal fluid blends containing 1,2,3,4-tetrahydro(1-phenylethyl)naphthalene
ZA200003377B (en) Serine carbonates.
HU0002132D0 (en) New arylpiperazinyl-3(2h)-piridazinones
EP1092021A4 (en) NPY-Y7 RECEPTOR GENE
GB2337989B (en) Intermediates and improved processes for the preparation of neplanocin A
AUPP266398A0 (en) Improved nasal appliance
GB9826368D0 (en) Promoter
GB9816775D0 (en) Herpesviral vectors for gene delivery
GB9820970D0 (en) Promoter
TW376901U (en) Improvement of the shell structure for the conveying equipment
SI1141254T1 (sl) Uporaba ksilanaze za pripravo zivila
TW324239U (en) Badminton service machine
AU2002225910A1 (en) Transgenic mice containing kir5.1 inwardly rectifying potassium channel gene disruptions
TW371059U (en) Connecting structure of CUP cassette
TW380646U (en) Improvement of the dying machine
TW361757U (en) Improvement for the shell assembly of scanning machine
GB9801996D0 (en) Furnace brazing
TW325663U (en) Improved thermal cup